Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period.

Maga P, Sanak M, Jawien J, Rewerska B, Maga M, Wachsmann A, Koziej M, Gregorczyk-Maga I, Nizankowski R.

J Physiol Pharmacol. 2016 Jun;67(3):377-83.

2.

Infrared thermography as option for evaluating the treatment effect of percutaneous transluminal angioplasty by patients with peripheral arterial disease.

Staffa E, Bernard V, Kubicek L, Vlachovsky R, Vlk D, Mornstein V, Bourek A, Staffa R.

Vascular. 2017 Feb;25(1):42-49. doi: 10.1177/1708538116640444. Epub 2016 Jul 9.

PMID:
26993145
3.

Perfusion measurements of the calf in patients with peripheral arterial occlusive disease before and after percutaneous transluminal angioplasty using MR arterial spin labeling.

Grözinger G, Pohmann R, Schick F, Grosse U, Syha R, Brechtel K, Rittig K, Martirosian P.

J Magn Reson Imaging. 2014 Oct;40(4):980-7. doi: 10.1002/jmri.24463. Epub 2013 Nov 15.

PMID:
24243496
4.

C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers.

Lin CW, Hsu LA, Chen CC, Yeh JT, Sun JH, Lin CH, Chen ST, Hsu BR, Huang YY.

Diabetes Res Clin Pract. 2010 Nov;90(2):167-72. doi: 10.1016/j.diabres.2010.08.002. Epub 2010 Sep 6.

PMID:
20822820
5.

Health-related quality of life in patients with peripheral arterial disease undergoing percutaneous transluminal angioplasty: a prospective one-year follow-up.

Egberg L, Mattiasson AC, Ljungström KG, Styrud J.

J Vasc Nurs. 2010 Jun;28(2):72-7. doi: 10.1016/j.jvn.2010.02.001.

PMID:
20494298
6.

Effects of percutaneous transluminal angioplasty on muscle BOLD-MRI in patients with peripheral arterial occlusive disease: preliminary results.

Huegli RW, Schulte AC, Aschwanden M, Thalhammer C, Kos S, Jacob AL, Bilecen D.

Eur Radiol. 2009 Feb;19(2):509-15. doi: 10.1007/s00330-008-1168-6. Epub 2008 Sep 16.

PMID:
18795296
7.

Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease.

Kumada Y, Aoyama T, Ishii H, Tanaka M, Kawamura Y, Takahashi H, Toriyama T, Aoyama T, Yuzawa Y, Maruyama S, Matsuo S, Murohara T.

Nephrol Dial Transplant. 2008 Dec;23(12):3996-4001. doi: 10.1093/ndt/gfn378. Epub 2008 Jul 2.

PMID:
18596131
8.

[Percutaneous transluminal angioplasty in treatment of lower limb peripheral arterial disease in diabetes patients: analysis of 150 cases].

Zhuang BX, Ma LB, Yu CL, Zhang T, Yang M, Shi B, Shi DZ.

Zhonghua Yi Xue Za Zhi. 2007 Jul 10;87(26):1821-4. Chinese.

PMID:
17922990
11.

Influence of percutaneous transluminal angioplasty on transcutaneous oxygen pressure in patients with peripheral arterial occlusive disease.

Wagner HJ, Schmitz R, Alfke H, Klose KJ.

Radiology. 2003 Mar;226(3):791-7. Epub 2003 Jan 15.

PMID:
12601207
12.

Clinical long-term results of percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease.

Bucek RA, Hudak P, Schnürer G, Ahmadi R, Wolfram RM, Minar E.

Vasa. 2002 Feb;31(1):36-42.

PMID:
11951697
13.

Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.

Roller RE, Janisch S, Carroll V, Kvas E, Pilger E, Binder BR, Wojta J.

Thromb Res. 1999 May 15;94(4):241-7.

PMID:
10336240
14.

Supplemental Content

Loading ...
Support Center